Table 2.
Genes significantly upregulated (>1.5-fold, P<0.1) by the combination of HGF and VEGF at 4 h
| Sequence derived from | Gene symbol | Gene description | Ratio of HGF+VEGF basal | P-value | Ratio of VEGF basal | P-value | Ratio of HGF basal | P-value |
|---|---|---|---|---|---|---|---|---|
| AK023795.1 | ADAMTS1 | A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 1 | 4.6 | <0.01 | 4.8 | <0.01 | 0.9 | 0.69 |
| AB003476.1 | AKAP12 | A kinase (PRKA) anchor protein (gravin) 12 | 1.6 | <0.01 | 1.2 | 0.31 | 1.6 | <0.01 |
| M90360.1 | AKAP13 | A kinase (PRKA) anchor protein 13 | 1.6 | 0.04 | 2.0 | <0.01 | 1.3 | 0.35 |
| NM_001147.1 | ANGPT2 | Angiopoietin 2 | 3.2 | <0.01 | 5.1 | <0.01 | 2.8 | <0.01 |
| AF187858.1 | ANGPT2 | Angiopoietin 2 | 3.2 | <0.01 | 4.6 | <0.01 | 2.7 | <0.01 |
| NM_015985.1 | ANGPT4 | Angiopoietin 4 | 3.0 | 0.08 | 0.9 | 0.85 | 0.7 | 0.52 |
| NM_016109.1 | ANGPTL4 | Angiopoietin-like 4 | 7.6 | <0.01 | 4.6 | <0.01 | 1.7 | 0.41 |
| NM_012099.1 | ASE-1 | CD3-epsilon-associated protein; antisense to ERCC-1 | 1.8 | 0.02 | 1.3 | 0.35 | 1.7 | 0.06 |
| NM_001673.1 | ASNS | Asparagine synthetase | 1.5 | 0.02 | 1.3 | 0.25 | 1.5 | 0.07 |
| AF095192.1 | BAG2 | BCL2-associated athanogene 2 | 1.7 | <0.01 | 1.1 | 0.8 | 1.4 | 0.23 |
| NM_004049.1 | BCL2A1 | BCL2-related protein A1 | 6.3 | <0.01 | 2.0 | 0.23 | 2.8 | 0.09 |
| AA583044 | BMP2 | Bone morphogenetic protein 2 | 2.0 | <0.01 | 2.1 | <0.01 | 1.7 | <0.01 |
| NM_001200.1 | BMP2 | Bone morphogenetic protein 2 | 1.9 | <0.01 | 1.7 | <0.01 | 1.4 | <0.01 |
| NM_001717.1 | BNC | Basonuclin | 1.9 | 0.09 | 1.6 | 0.32 | 1.6 | 0.37 |
| NM_025195.1 | C8FW | Phosphoprotein regulated by mitogenic pathways | 2.1 | <0.01 | 1.5 | 0.08 | 1.5 | <0.01 |
| NM_005795.1 | CALCRL | Calcitonin receptor-like | 1.5 | <0.01 | 1.2 | 0.17 | 1.0 | 0.89 |
| U17473.1 | CALCRL | Calcitonin receptor-like | 1.5 | 0.01 | 1.2 | 0.32 | 1.1 | 0.71 |
| NM_016557.1 | CCRL1 | Chemokine (C–C motif) receptor-like 1 | 7.2 | <0.01 | 5.8 | <0.01 | 1.8 | 0.01 |
| AV700298 | CD44 | CD44 antigen (homing function and Indian blood group system) | 2.0 | 0.06 | 2.3 | 0.06 | 1.9 | 0.09 |
| NM_003672.1 | CDC14A | CDC14 cell division cycle 14 homolog A (S. cerevisiae) | 1.9 | 0.01 | 2.2 | 0.01 | 1.8 | 0.1 |
| AF115544.1 | CDKN2A | Cyclin-dependent kinase inhibitor 2A(melanoma, p16, inhibits CDK4) | 4.3 | 0.07 | 3.5 | 0.16 | 1.4 | 0.81 |
| BC000059.1 | CELSR1 | Cadherin, EGF LAG seven-pass G-typereceptor 1 (flamingo homolog, Drosophila) | 2.5 | 0.05 | 2.5 | 0.14 | 1.7 | 0.52 |
| NM_021797.1 | CHIA | Eosinophil chemotactic cytokine | 3.0 | 0.01 | 1.0 | 0.93 | 2.2 | 0.38 |
| NM_000748.1 | CHRNB2 | Cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) | 6.8 | 0.03 | 2.1 | 0.7 | 3.0 | 0.6 |
| NM_013246.1 | CLC | Cardiotrophin-like cytokine; neurotrophin-1/B-cell-stimulating factor-3 | 2.6 | 0.1 | 1.5 | 0.58 | 1.9 | 0.29 |
| NM_001842.1 | CNTFR | Ciliary neurotrophic factor receptor | 2.8 | 0.02 | 2.3 | 0.08 | 1.9 | 0.63 |
| NM_004750.1 | CRLF1 | Cytokine receptor-like factor 1 | 5.6 | 0.03 | 0.7 | 0.71 | 3.1 | 0.44 |
| D83702.1 | CRY1 | Cryptochrome 1 (photolyase-like) | 1.9 | <0.01 | 1.9 | <0.01 | 1.1 | 0.42 |
| BC005921.1 | CSH1 | Chorionic somatomammotropin hormone 1 (placental lactogen) | 4.0 | 0.01 | 2.0 | 0.5 | 3.2 | 0.13 |
| U83410.1 | CUL2 | Cullin 2 | 2.0 | 0.02 | 1.7 | 0.26 | 2.0 | 0.16 |
| L01639.1 | CXCR4 | Chemokine (C–X–C motif) receptor 4 | 3.0 | <0.01 | 2.8 | <0.01 | 4.2 | <0.01 |
| AJ224869 | CXCR4 | Chemokine (C–X–C motif) receptor 4 | 2.4 | <0.01 | 2.5 | <0.01 | 3.0 | <0.01 |
| AF348491.1 | CXCR4 | Chemokine (C–X–C motif) receptor 4 | 1.9 | <0.01 | 1.7 | 0.04 | 2.2 | 0.02 |
| BC003637.1 | DDIT3 | DNA-damage-inducible transcript 3 | 1.9 | <0.01 | 3.3 | <0.01 | 1.6 | 0.1 |
| AL050069.1 | DOK5 | Docking protein 5 | 3.1 | <0.0 | 1.5 | 0.16 | 1.0 | 0.81 |
| NM_000796.1 | DRD3 | Dopamine receptor D3 | 2.6 | 0.02 | 1.5 | 0.38 | 2.5 | 0.13 |
| M60278 | DTR | Diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor) | 2.6 | <0.01 | 3.8 | <0.01 | 0.7 | <0.01 |
| NM_001945.1 | DTR | Diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor) | 2.2 | <0.01 | 3.1 | <0.01 | 0.7 | 0.04 |
| BC002671.1 | DUSP4 | Dual specificity phosphatase 4 | 9.3 | <0.01 | 8.5 | <0.01 | 3.8 | 0.11 |
| NM_001394.2 | DUSP4 | Dual specificity phosphatase 4 | 5.8 | <0.01 | 6.5 | <0.01 | 2.8 | 0.03 |
| BC005047.1 | DUSP6 | Dual specificity phosphatase 6 | 7.2 | <0.01 | 6.3 | <0.01 | 3.2 | 0.03 |
| BC003143.1 | DUSP6 | Dual specificity phosphatase 6 | 3.1 | <0.01 | 2.5 | <0.01 | 1.7 | <0.01 |
| BC003143.1 | DUSP6 | Dual specificity phosphatase 6 | 2.9 | <0.01 | 2.7 | <0.01 | 1.7 | <0.01 |
| NM_001964.1 | EGR1 | Early growth response 1 | 4.7 | <0.01 | 5.8 | <0.01 | 4.4 | <0.01 |
| NM_012153.1 | EHF | ets homologous factor | 2.3 | 0.05 | 1.1 | 0.88 | 1.4 | 0.64 |
| BF445047 | EMP1 | Epithelial membrane protein 1 | 3.2 | <0.01 | 1.9 | <0.01 | 1.9 | <0.01 |
| NM_001423.1 | EMP1 | Epithelial membrane protein 1 | 2.1 | <0.01 | 1.5 | <0.01 | 1.6 | <0.01 |
| NM_001423.1 | EMP1 | Epithelial membrane protein 1 | 1.7 | <0.01 | 1.5 | <0.01 | 1.4 | <0.01 |
| NM_004438.1 | EPHA4 | EphA4 | 3.1 | 0.06 | 1.8 | 0.2 | 2.2 | 0.18 |
| NM_001993.2 | F3 | Coagulation factor III (thromboplastin, tissue factor) | 7.8 | <0.01 | 19.1 | <0.01 | 0.8 | 0.84 |
| NM_012306.1 | FAIM2 | Fas apoptotic inhibitory molecule 2 | 3.2 | 0.02 | 2.5 | 0.05 | 3.0 | <0.01 |
| NM_003868.1 | FGF16 | Fibroblast growth factor 16 | 2.1 | 0.03 | 1.6 | 0.12 | 1.1 | 0.57 |
| U01134.1 | FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 13.5 | <0.01 | 4.3 | <0.01 | 2.7 | 0.01 |
| NM_006732.1 | FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 7.4 | <0.01 | 1.2 | 0.9 | 1.0 | 1 |
| BG251266 | FOSL1 | FOS-like antigen 1 | 1.9 | <0.01 | 1.4 | <0.01 | 1.3 | 0.02 |
| NM_005261.1 | GEM | GTP binding protein overexpressed in skeletal muscle | 1.5 | 0.01 | 1.3 | 0.34 | 1.0 | 0.99 |
| U35399.1 | GPR4 | G protein-coupled receptor 4 | 1.7 | 0.08 | 1.4 | 0.37 | 1.8 | 0.04 |
| AL554008 | GPR56 | G protein-coupled receptor 56 | 1.9 | <0.01 | 1.1 | 0.68 | 1.5 | 0.03 |
| U66065.1 | GRB10 | Growth factor receptor-bound protein 10 | 1.7 | <0.01 | 1.2 | 0.01 | 1.6 | <0.01 |
| D86962.1 | GRB10 | Growth factor receptor-bound protein 10 | 1.7 | <0.01 | 1.3 | 0.03 | 1.5 | <0.01 |
| NM_004490.1 | GRB14 | Growth factor receptor-bound protein 14 | 1.6 | <0.01 | 1.1 | 0.47 | 1.7 | <0.01 |
| NM_021643.1 | GS3955 | GS3955 protein | 1.9 | 0.09 | 1.8 | 0.08 | 0.8 | 0.58 |
| AI761561 | HK2 | Hexokinase 2 | 3.5 | <0.01 | 1.5 | 0.06 | 2.6 | <0.01 |
| NM_000872.2 | HTR7 | 5-Hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) | 2.6 | 0.1 | 2.1 | 0.14 | 1.7 | 0.49 |
| AA284705 | ICAM1 | Intercellular adhesion molecule 1 (CD54), Human rhinovirus receptor | 1.8 | 0.07 | 2.0 | 0.03 | 1.5 | 0.31 |
| NM_000201.1 | ICAM1 | Intercellular adhesion molecule 1 (CD54), Human rhinovirus receptor | 1.8 | <0.01 | 2.6 | <0.01 | 1.1 | 0.22 |
| AI608725 | ICAM1 | Intercellular adhesion molecule 1 (CD54), Human rhinovirus receptor | 1.7 | <0.01 | 1.8 | <0.01 | 1.0 | 0.86 |
| M31159.1 | IGFBP3 | Insulin-like growth factor binding protein 3 | 5.5 | <0.01 | 2.5 | <0.01 | 0.8 | 0.65 |
| NM_000641.1 | IL11 | Interleukin 11 | 3.4 | <0.01 | 2.2 | 0.04 | 1.7 | 0.22 |
| BF112057 | IL-17RC | Interleukin 17 receptor C | 4.5 | 0.06 | 2.3 | 0.44 | 2.1 | 0.5 |
| NM_000600.1 | IL6 | Interleukin 6 (interferon, beta 2) | 1.7 | <0.01 | 3.1 | <0.01 | 1.1 | 0.59 |
| AF043337.1 | IL8 | Interleukin 8 | 2.3 | <0.01 | 3.2 | <0.01 | 0.9 | 0.68 |
| NM_000584.1 | IL8 | Interleukin 8 | 1.9 | <0.01 | 2.1 | 0.02 | 1.0 | 0.88 |
| NM_002192.1 | INHBA | Inhibin, beta A (activin A, activin AB alpha polypeptide) | 1.6 | 0.04 | 2.2 | 0.04 | 1.0 | 0.94 |
| NM_002201.2 | ISG20 | Interferon-stimulated gene 20 k Da | 6.8 | 0.03 | 3.3 | 0.35 | 1.9 | 0.65 |
| U88964 | ISG20 | Interferon-stimulated gene 20 k Da | 1.9 | <0.01 | 1.2 | 0.47 | 1.4 | 0.18 |
| NM_002203.2 | ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 1.9 | <0.01 | 1.5 | 0.14 | 1.7 | <0.01 |
| AV733308 | ITGA6 | integrin, alpha 6 | 1.6 | <0.01 | 1.3 | 0.11 | 1.1 | 0.41 |
| AA215854 | ITGB1 | Integrin, beta 1 (Fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 2.6 | 0.04 | 3.3 | 0.04 | 2.2 | 0.11 |
| NM_002214.1 | ITGB8 | Integrin, beta 8 | 4.1 | <0.01 | 2.6 | 0.04 | 2.8 | <0.01 |
| BC002630.1 | ITGB8 | Integrin, beta 8 | 1.7 | 0.08 | 0.9 | 0.82 | 1.1 | 0.86 |
| L38019.1 | ITPR1 | Inositol 1,4,5-triphosphate receptor, type 1 | 4.5 | 0.04 | 4.9 | <0.01 | 2.4 | 0.35 |
| NM_002224.1 | ITPR3 | Inositol 1,4,5-triphosphate receptor, type 3 | 1.7 | 0.03 | 0.9 | 0.64 | 1.1 | 0.57 |
| AL137000 | KIAA0970 | KIAA0970 protein | 1.7 | 0.05 | 1.9 | <0.01 | 1.1 | 0.81 |
| AF119835.1 | KITLG | KIT ligand | 4.3 | <0.01 | 2.2 | 0.1 | 1.4 | 0.53 |
| NM_000899.1 | KITLG | KIT ligand | 2.8 | <0.01 | 1.8 | 0.01 | 1.3 | 0.15 |
| NM_012302.1 | LPHH1 | Latrophilin 1 | 2.5 | <0.01 | 2.1 | <0.01 | 1.7 | <0.01 |
| NM_017522.1 | LRP8 | Low-density lipoprotein receptor-related protein 8, apolipoprotein e receptor | 1.9 | 0.02 | 1.0 | 0.97 | 1.4 | 0.42 |
| AA780381 | MAP2K3 | Mitogen-activated protein kinase kinase 3 | 5.9 | <0.01 | 3.5 | <0.01 | 3.2 | <0.01 |
| AA780381 | MAP2K3 | Mitogen-activated protein kinase kinase 3 | 2.6 | <0.01 | 1.6 | <0.01 | 1.5 | <0.01 |
| NM_002756.1 | MAP2K3 | Mitogen-activated protein kinase kinase 3 | 2.5 | <0.01 | 1.5 | 0.02 | 1.5 | <0.01 |
| NM_005204.1 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | 2.4 | 0.03 | 3.8 | <0.01 | 0.9 | 0.73 |
| NM_004759.1 | MAPKAPK2 | Mitogen-activated protein kinase activated protein kinase 2 | 1.5 | <0.01 | 1.4 | <0.01 | 1.0 | 0.7 |
| NM_000381.1 | MID1 | Midline 1 (Opitz/BBB syndrome) | 1.5 | <0.01 | 1.7 | <0.01 | 1.2 | 0.3 |
| AL545921 | MPHOSPH10 | M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein) | 1.5 | 0.02 | 1.5 | 0.02 | 1.1 | 0.44 |
| NM_002467.1 | MYC | V-myc myelocytomatosis viral oncogene homolog (avian) | 1.5 | <0.01 | 1.0 | 0.67 | 1.2 | 0.07 |
| BF337329 | NAB2 | NGFI-A binding protein 2 (EGR1 binding protein 2) | 10.0 | <0.01 | 7.4 | <0.01 | 5.1 | 0.01 |
| U08015.1 | NFATC1 | Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 1.7 | <0.01 | 1.1 | 0.19 | 0.9 | 0.58 |
| AW027545 | NFATC1 | Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 1.7 | 0.07 | 1.2 | 0.57 | 0.9 | 0.73 |
| M55643.1 | NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | 1.5 | 0.01 | 1.3 | 0.23 | 1.1 | 0.26 |
| NM_006170.1 | NOL1 | Nucleolar protein1, 120 k Da | 1.6 | <0.01 | 1.1 | 0.59 | 1.3 | <0.01 |
| D21262.1 | NOLC1 | Nucleolar and coiled-body phosphoprotein 1 | 2.3 | <0.01 | 1.4 | 0.01 | 1.9 | <0.01 |
| NM_000271.1 | NPC1 | Niemann–Pick disease, type C1 | 1.6 | <0.01 | 1.0 | 0.76 | 1.3 | 0.05 |
| D49728.1 | NR4A1 | Nuclear receptor subfamily 4, group A, member 1 | 7.9 | <0.01 | 8.1 | <0.01 | 1.6 | 0.79 |
| NM_002135.1 | NR4A1 | Nuclear receptor subfamily 4, group A, member 1 | 6.6 | <0.01 | 8.5 | 0.03 | 1.0 | 0.98 |
| S77154.1 | NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | 3.6 | <0.01 | 2.6 | 0.02 | 0.8 | 0.63 |
| NM_006186.1 | NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | 2.4 | 0.01 | 2.3 | 0.06 | 1.0 | 0.95 |
| U12767.1 | NR4A3 | Nuclear receptor subfamily 4, group A,member 3 | 3.1 | <0.01 | 3.5 | 0.26 | 1.3 | 0.84 |
| AF146343.1 | NR5A2 | Nuclear receptor subfamily 5, group A, member 2 | 4.3 | <0.01 | 4.2 | <0.01 | 2.6 | <0.01 |
| AF228413.1 | NR5A2 | Nuclear receptor subfamily 5, group A, member 2 | 3.2 | <0.01 | 2.6 | 0.09 | 2.4 | 0.07 |
| NM_003822.1 | NR5A2 | Nuclear receptor subfamily 5, group A, member 2 | 2.4 | 0.09 | 2.2 | 0.11 | 1.9 | 0.18 |
| NM_005010.1 | NRCAM | Neuronal cell adhesion molecule | 1.9 | <0.01 | 1.7 | <0.01 | 1.7 | <0.01 |
| NM_013960.1 | NRG1 | Neuregulin 1 | 1.5 | 0.08 | 1.0 | 0.93 | 1.2 | 0.59 |
| NM_012377.1 | OR7C2 | Olfactory receptor, family 7, subfamily C, member 2 | 5.4 | 0.04 | 1.5 | 0.58 | 1.3 | 0.42 |
| X03795.1 | PDGFA | Platelet-derived growth factor alpha polypeptide | 4.1 | 0.03 | 1.4 | 0.61 | 1.7 | 0.44 |
| NM_002607.1 | PDGFA | Platelet-derived growth factor alpha polypeptide | 3.0 | <0.01 | 1.1 | 0.44 | 1.8 | <0.01 |
| NM_007169.1 | PEMT | Phosphatidylethanolamine N-methyltransferase | 1.7 | 0.1 | 1.3 | 0.67 | 1.5 | 0.4 |
| AA576961 | PHLDA1 | Pleckstrin homology-like domain, family A, member 1 | 1.7 | <0.01 | 1.3 | 0.17 | 1.1 | 0.56 |
| NM_006875.1 | PIM2 | pim-2 oncogene | 1.7 | 0.02 | 1.6 | <0.01 | 1.0 | 0.85 |
| NM_002658.1 | PLAU | Plasminogen activator, urokinase | 1.8 | <0.01 | 1.3 | 0.05 | 0.7 | <0.01 |
| K03226.1 | PLAU | Plasminogen activator, urokinase | 1.7 | <0.01 | 1.1 | 0.53 | 0.6 | <0.01 |
| AY029180.1 | PLAUR | Plasminogen activator, urokinase receptor | 7.8 | <0.01 | 3.3 | 0.03 | 2.8 | 0.03 |
| U08839.1 | PLAUR | Plasminogen activator, urokinase receptor | 3.3 | <0.01 | 1.7 | <0.01 | 1.6 | <0.01 |
| NM_025179.1 | PLXNA2 | Plexin A2 | 1.8 | 0.01 | 1.7 | <0.01 | 1.3 | 0.17 |
| AI688418 | PLXNA2 | Plexin A2 | 1.6 | <0.01 | 1.4 | <0.01 | 1.2 | <0.01 |
| NM_002674.1 | PMCH | Pro-melanin-concentrating hormone | 17.0 | <0.01 | 5.6 | <0.01 | 2.1 | 0.47 |
| L03203.1 | PMP22 | Peripheral myelin protein 22 | 2.8 | <0.01 | 2.0 | <0.01 | 1.6 | <0.01 |
| NM_003967.1 | PNR | Putative neurotransmitter receptor | 3.5 | 0.1 | 1.1 | 0.97 | 0.4 | 0.58 |
| BC000535.1 | PPAN | Peter pan homolog (Drosophila) | 2.3 | 0.08 | 1.3 | 0.49 | 1.3 | 0.49 |
| AF014403.1 | PPAP2A | Phosphatidic acid phosphatase type 2A | 1.8 | <0.01 | 2.8 | <0.01 | 1.1 | 0.34 |
| AB000888.1 | PPAP2A | Phosphatidic acid phosphatase type 2A | 1.8 | <0.01 | 2.5 | <0.01 | 1.1 | 0.62 |
| AB000889.1 | PPAP2B | Phosphatidic acid phosphatase type 2B | 6.3 | <0.01 | 4.8 | <0.01 | 1.7 | <0.01 |
| AL576654 | PPAP2B | Phosphatidic acid phosphatase type 2B | 4.4 | <0.01 | 3.5 | <0.01 | 1.5 | <0.01 |
| BC005961.1 | PTHLH | Parathyroid hormone-like hormone | 13.2 | <0.01 | 2.8 | 0.07 | 6.0 | <0.01 |
| NM_002820.1 | PTHLH | Parathyroid hormone-like hormone | 7.8 | <0.01 | 1.7 | 0.28 | 2.9 | <0.01 |
| J03580.1 | PTHLH | Parathyroid hormone-like hormone | 3.6 | 0.01 | 1.0 | 0.96 | 1.7 | 0.32 |
| NM_002849.1 | PTPRR | Protein tyrosine phosphatase, receptor type, R | 2.3 | 0.05 | 1.4 | 0.63 | 1.7 | 0.41 |
| BE615277 | PVR | Poliovirus receptor | 1.5 | <0.01 | 1.3 | 0.29 | 1.1 | 0.59 |
| NM_000319.1 | PXR1 | Peroxisome receptor 1 | 1.5 | 0.05 | 1.2 | 0.34 | 1.2 | 0.2 |
| AI817041 | RDC1 | G protein-coupled receptor | 1.7 | <0.01 | 1.5 | 0.12 | 0.9 | 0.45 |
| NM_002923.1 | RGS2 | Regulator of G-protein signalling 2, 24 k Da | 4.5 | <0.01 | 2.1 | <0.01 | 1.5 | <0.01 |
| BF062629 | RIS1 | Ras-induced senescence 1 | 7.6 | <0.01 | 1.8 | 0.26 | 2.8 | 0.02 |
| NM_002575.1 | SERPINB2 | Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 2 | 3.5 | <0.01 | 1.5 | 0.13 | 2.5 | <0.01 |
| NM_003012.2 | SFRP1 | Secreted frizzled-related protein 1 | 2.0 | 0.02 | 1.2 | 0.51 | 1.3 | 0.37 |
| AF017987.1 | SFRP1 | Secreted frizzled-related protein 1 | 1.7 | 0.05 | 1.1 | 0.8 | 1.0 | 0.84 |
| NM_005627.1 | SGK | Serum/glucocorticoid regulated kinase | 2.0 | <0.01 | 2.1 | <0.01 | 1.2 | 0.24 |
| AF153330.1 | SLC19A2 | Solute carrier family 19 (thiamine transporter), member 2 | 1.7 | 0.01 | 1.3 | 0.11 | 1.4 | 0.09 |
| NM_005415.2 | SLC20A1 | Solute carrier family 20 (phosphate transporter), member 1 | 2.8 | <0.01 | 1.4 | <0.01 | 1.9 | <0.01 |
| AW452623 | SLC7A1 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | 2.1 | <0.01 | 2.1 | 0.01 | 1.2 | 0.51 |
| NM_003045.1 | SLC7A1 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | 2.0 | 0.02 | 1.9 | 0.08 | 0.8 | 0.37 |
| NM_014720.1 | SLK | Ste20-related serine/threonine kinase | 1.5 | 0.04 | 1.3 | 0.08 | 1.1 | 0.36 |
| AB004903.1 | SOCS2 | Suppressor of cytokine signaling 2 | 2.3 | 0.05 | 1.4 | 0.55 | 1.7 | 0.29 |
| NM_003877.1 | SOCS2 | Suppressor of cytokine signaling 2 | 1.8 | 0.06 | 1.1 | 0.74 | 0.9 | 0.77 |
| NM_003155.1 | STC1 | Stanniocalcin 1 | 30.9 | <0.01 | 7.8 | <0.01 | 1.4 | 0.44 |
| AI300520 | STC1 | Stanniocalcin1 | 12.9 | <0.01 | 3.6 | 0.03 | 0.8 | 0.47 |
| U46768.1 | STC1 | Stanniocalcin 1 | 11.0 | <0.01 | 4.3 | <0.01 | 1.1 | 0.87 |
| NM_005990.1 | STK10 | Serine/threonine kinase 10 | 1.9 | 0.01 | 1.9 | 0.08 | 1.1 | 0.68 |
| BE550452 | SYN47 | Homer, neuronal immediate early gene, 1B | 2.6 | 0.09 | 2.5 | 0.12 | 2.5 | 0.07 |
| NM_015727.1 | TACR1 | Tachykinin receptor 1 | 3.4 | 0.1 | 2.7 | 0.21 | 3.4 | 0.05 |
| J04152 | TACSTD2 | Tumor-associated calcium signal transducer 2 | 1.9 | <0.01 | 1.1 | 0.5 | 1.1 | 0.55 |
| D38081 | TBXA2R | Thromboxane A2 receptor | 1.5 | 0.04 | 0.9 | 0.55 | 1.3 | 0.1 |
| NM_030751.1 | TCF8 | Transcription factor 8 (represses interleukin 2 expression) | 1.9 | 0.02 | 1.5 | 0.15 | 1.6 | 0.14 |
| NM_000361.1 | THBD | Thrombomodulin | 4.9 | <0.01 | 3.4 | <0.01 | 1.4 | 0.04 |
| NM_000361.1 | THBD | Thrombomodulin | 4.9 | <0.01 | 3.1 | 0.06 | 1.3 | 0.7 |
| NM_003254.1 | TIMP1 | Tissue inhibitor of metalloproteinase 1 (erythroid potentiating activity, collagenase inhibitor) | 1.7 | <0.01 | 1.2 | 0.1 | 1.4 | <0.01 |
| NM_003823.1 | TNFRSF6B | Tumor necrosis factor receptor superfamily, member 6b, decoy | 1.6 | <0.01 | 0.9 | 0.77 | 1.3 | 0.21 |
| NM_005118.1 | TNFSF15 | Tumor necrosis factor (ligand) superfamily, member 15 | 2.2 | <0.01 | 1.6 | 0.16 | 1.3 | 0.5 |
| NM_016179.1 | TRPC4 | Transient receptor potential cation channel, subfamily C, member 4 | 2.6 | 0.09 | 2.5 | 0.09 | 3.2 | <0.01 |
| AF001294.1 | TSSC3 | Tumor suppressing subtransferable candidate 3 | 1.6 | <0.01 | 1.0 | 0.84 | 1.5 | 0.04 |
| U58111.1 | VEGFC | Vascular endothelial growth factor C | 1.7 | <0.01 | 1.4 | 0.01 | 1.3 | 0.11 |
| AI983115 | WSX1 | Class I cytokine receptor | 3.8 | 0.02 | 1.9 | 0.43 | 3.1 | 0.06 |
| NM_004843.1 | WSX1 | Class I cytokine receptor | 2.2 | 0.09 | 1.0 | 0.94 | 1.4 | 0.44 |
| NM_005283.1 | XCR1 | Chemokine (C motif) receptor 1 | 3.2 | 0.03 | 2.8 | 0.27 | 3.2 | 0.15 |
| NM_016164.2 | XLKD1 | Extracellular link domain containing 1 | 2.2 | 0.06 | 2.8 | 0.07 | 0.6 | 0.58 |
| U87460.1 | Putative endothelin receptor type B-like protein [Homo sapiens], mRNA sequence | 5.1 | <0.01 | 4.2 | <0.01 | 2.4 | 0.19 | |
| NM_004367.1 | Chemokine (C–C motif) receptor 6; chemokine (C–C) receptor 6; G proteincoupled receptor 29; seven-transmembrane receptor, lymphocyte, 22; chemokine receptor-like 3 [Homo sapiens], mRNA sequence | 2.3 | 0.09 | 1.7 | 0.3 | 1.4 | 0.6 | |
| AA058828 | Soluble vascular endothelial cell growth factor receptor (A49636) | 1.7 | 0.03 | 2.6 | 0.01 | 1.5 | 0.02 |